HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

13.800

-0.290-2.06%

Volume:1.30M

Turnover:18.03M

Market Cap:5.96B

PE:2.09K

High:14.320

Open:14.300

Low:13.790

Close:14.090

52wk High:48.800

52wk Low:13.360

Shares:432.00M

HK Float Shares:323.00M

Volume Ratio:0.22

T/O Rate:0.40%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.007

ROE:0.21%

ROA:-0.83%

PB:3.81

PE(LYR):2,090.91

PS:11.70

Loading ...

Overview Company News Filings

CF PHARMTECH (02652) Receives NMPA Acceptance for IND Application of Self-Developed Inhalation Powder ICF001

CF PharmTech says NMPA accepts IND application for ICF001 inhalation powder

CF Pharmtech Inc - Nmpa Accepts Ind Application for ICF001 Inhalation Powder

THOMSON REUTERS

Global Reformulation Breakthrough! CF PHARMTECH's Pulmonary Hypertension Drug IND Accepted

Hong Kong Market Announcement Highlights | Mengniu Dairy Projects Annual Attributable Profit of Approximately RMB 1.4 to 1.6 Billion

CF PHARMTECH (02652) Receives CTA Approval for Combined Nasal Spray Targeting Allergic Rhinitis

Bulletin Express

CF PHARMTECH (02652) Receives NMPA Approval for Clinical Trial Application of Olopatadine Mometasone Nasal Spray

CF Pharmtech Inc - Approval of Clinical Trial Application for Olopatadine Hydrochloride and Mometasone Furoate Monohydrate Nasal Spray by Nmpa

THOMSON REUTERS

CF PharmTech wins NMPA clinical trial approval for olopatadine-mometasone nasal spray

CF PHARMTECH (02652) Included in Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs

CF PHARMTECH (02652) Included in Shanghai-HK and Shenzhen-HK Stock Connect

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/02652/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":13.8,"timestamp":1788250093007,"preClose":14.09,"halted":0,"volume":1296000,"delay":0,"changeRate":-0.020581973030518036,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"Not Yet Opened","change":-0.29,"latestTime":"09-01 16:08:13","open":14.3,"high":14.32,"low":13.79,"amount":18034802,"amplitude":0.037615,"askPrice":13.84,"askSize":3600,"bidPrice":13.8,"bidSize":13200,"shortable":3,"etf":0,"ttmEps":0.006,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":14.09,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":0.2237615420228299,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":323000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.0066,"volumeRatio":0.2237615420228299,"shares":432000000,"dividePrice":0,"high":14.32,"amplitude":0.037615,"preClose":14.09,"low":13.79,"week52Low":13.36,"pbRate":"3.81","psRate":"11.70","week52High":48.8,"institutionHeld":0,"latestPrice":13.8,"committee":0.571429,"eps":0.0066,"divideRate":0,"volume":1296000,"delay":0,"ttmEps":0.006,"open":14.3,"prevYearClose":35,"prevWeekClose":14.51,"prevMonthClose":14.09,"prevQuarterClose":21,"fiveDayClose":15.63,"twentyDayClose":17.14,"sixtyDayClose":20.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-08-31","current":2300,"percent":0.541284,"low":-293.764894,"twenty":420.87072,"median":500.357252,"eighty":2816.151939,"high":3595.964728,"avg":1491.106328,"sd":1181.953256,"marketCap":5785091742},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-05","current":2895.334441,"twenty":400.969089,"median":468.273561,"eighty":2926.706614,"marketCap":8327404730},{"date":"2026-06-12","current":2591.262092,"twenty":402.338985,"median":469.314298,"eighty":2919.612019,"marketCap":7447807192},{"date":"2026-06-18","current":2679.987141,"twenty":403.474666,"median":471.144686,"eighty":2910.923271,"marketCap":7719084937},{"date":"2026-06-26","current":2653.65777,"twenty":407.739322,"median":472.774581,"eighty":2903.774482,"marketCap":7608107678},{"date":"2026-07-03","current":2674.595079,"twenty":410.258066,"median":474.904398,"eighty":2905.018632,"marketCap":7673871980},{"date":"2026-07-10","current":2510.065653,"twenty":411.453021,"median":477.841604,"eighty":2898.212797,"marketCap":7192970522},{"date":"2026-07-17","current":2212.458756,"twenty":411.611884,"median":479.42962,"eighty":2892.703479,"marketCap":6362696210},{"date":"2026-07-24","current":2249.530522,"twenty":411.787912,"median":481.475073,"eighty":2888.435745,"marketCap":6470762659},{"date":"2026-07-31","current":2830.800739,"twenty":412.509722,"median":482.52515,"eighty":2884.270453,"marketCap":8158252159},{"date":"2026-08-07","current":2582.169982,"twenty":413.490204,"median":483.399827,"eighty":2872.355071,"marketCap":7456157987},{"date":"2026-08-14","current":2399.972298,"twenty":415.255724,"median":487.118208,"eighty":2848.370255,"marketCap":6938825440},{"date":"2026-08-21","current":2153.795127,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"marketCap":6240837082},{"date":"2026-08-28","current":2055.558094,"twenty":420.751477,"median":499.411825,"eighty":2817.123583,"marketCap":5957535925},{"date":"2026-08-31","current":1996.908199,"twenty":420.87072,"median":500.357252,"eighty":2816.151939,"marketCap":5785091742}],"updateTime":1788295268048},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1126576438","title":"CF PHARMTECH (02652) Receives NMPA Acceptance for IND Application of Self-Developed Inhalation Powder ICF001","url":"https://stock-news.laohu8.com/highlight/detail?id=1126576438","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126576438?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:06","pubTimestamp":1773407187,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that the Investigational New Drug (IND) application for its self-developed inhalation powder candidate, ICF001, has been accepted by the National Medical Products...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619197090","title":"CF PharmTech says NMPA accepts IND application for ICF001 inhalation powder","url":"https://stock-news.laohu8.com/highlight/detail?id=2619197090","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619197090?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:04","pubTimestamp":1773407089,"startTime":"0","endTime":"0","summary":"CF Pharmtech said China’s National Medical Products Administration accepted its investigational new drug application for ICF001, an inhalation powder candidate. The filing is for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The applicant is CF Pharmtech Guangzhou, a subsidiary of the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDLbrycGY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619197455","title":"CF Pharmtech Inc - Nmpa Accepts Ind Application for ICF001 Inhalation Powder","url":"https://stock-news.laohu8.com/highlight/detail?id=2619197455","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619197455?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:00","pubTimestamp":1773406817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN4010IJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136781619","title":"Global Reformulation Breakthrough! CF PHARMTECH's Pulmonary Hypertension Drug IND Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=1136781619","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136781619?lang=en_us&edition=fundamental","pubTime":"2026-03-13 13:48","pubTimestamp":1773380909,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced on March 13 that the Investigational New Drug (IND) application for its self-developed inhaled powder ICF001 has been formally accepted by China's National Medical...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","IND","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112141928","title":"Hong Kong Market Announcement Highlights | Mengniu Dairy Projects Annual Attributable Profit of Approximately RMB 1.4 to 1.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1112141928","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112141928?lang=en_us&edition=fundamental","pubTime":"2026-03-09 09:17","pubTimestamp":1773019041,"startTime":"0","endTime":"0","summary":"Significant Corporate Developments: Hengrui Pharmaceuticals (01276) announced that its adebelisib injection has received a drug clinical trial approval notice. Anjoy Foods (02648) plans to inject an...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02319","LU0650527681.SGD","LU2045819591.USD","LU1102505762.USD","LU0370786039.SGD","SG9999011746.SGD","BK1597","BK4585","BK4588","IE00B29SXG58.USD","LU1115378108.SGD","LU1051768304.USD","LU0228659784.USD","LU0737861699.HKD","LU0823426308.USD","LU0588546209.SGD","LU1102505929.USD","LU0594300419.USD","LU0307460666.USD","BK1237","HK0000320264.USD","LU0287142896.SGD","LU0029875118.USD","LU0543330483.HKD","LU0328353924.USD","LU1048588211.SGD","BK1521","IE0008369823.USD","LU0251143458.SGD","VXUS","BK1553","IE0031814852.USD","LU0359202008.SGD","IE00B0169L03.USD","LU1769817096.USD","LU0128522157.USD","BK1191","HK0000306701.USD","LU1515016050.SGD","LU1769817179.HKD","LU0385154629.USD","VT","LU0326950275.SGD","IE00B97KM107.HKD","IE00B067MR52.USD","LU0823426480.USD","02575","HK0000306685.HKD","LU0173614495.USD","LU0640798160.USD","LU0228367735.SGD","LU0048580855.USD","LU1439103000.SGD","IE0032834883.USD","IE0008368742.USD","LU0651946864.USD","LU2125910500.SGD","IE0009570106.USD","LU0359201612.USD","LU0320764755.SGD","LU0259732245.USD","LU0315179316.USD","LU0348788117.USD","LU0359201885.HKD","LU1224709979.USD","LU0106959298.USD","BK1589","LU0072462343.USD","LU0211977185.USD","02652","IE00B031J352.USD","LU0471298777.SGD","SG9999002828.SGD","LU0163747925.USD","LU1023057109.AUD","IE00B031HY20.USD","HK0000320223.HKD","LU0672654166.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162637253","title":"CF PHARMTECH (02652) Receives CTA Approval for Combined Nasal Spray Targeting Allergic Rhinitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1162637253","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162637253?lang=en_us&edition=fundamental","pubTime":"2026-03-09 08:02","pubTimestamp":1773014569,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) received approval from the National Medical Products Administration for a clinical trial application (CTA) concerning a nasal spray that combines olopatadine hydrochloride and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169494763","title":"CF PHARMTECH (02652) Receives NMPA Approval for Clinical Trial Application of Olopatadine Mometasone Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=1169494763","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169494763?lang=en_us&edition=fundamental","pubTime":"2026-03-09 07:50","pubTimestamp":1773013823,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that the Clinical Trial Application (CTA) for its Olopatadine Mometasone Nasal Spray has been approved by the National Medical Products Administration (NMPA) of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618569405","title":"CF Pharmtech Inc - Approval of Clinical Trial Application for Olopatadine Hydrochloride and Mometasone Furoate Monohydrate Nasal Spray by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2618569405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618569405?lang=en_us&edition=fundamental","pubTime":"2026-03-09 07:44","pubTimestamp":1773013496,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260308:nFWN3ZU1HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618037694","title":"CF PharmTech wins NMPA clinical trial approval for olopatadine-mometasone nasal spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2618037694","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618037694?lang=en_us&edition=fundamental","pubTime":"2026-03-09 07:44","pubTimestamp":1773013477,"startTime":"0","endTime":"0","summary":"CF PharmTech said China’s NMPA approved its clinical trial application for an olopatadine hydrochloride and mometasone furoate monohydrate nasal spray. The product is a fixed-dose antihistamine and corticosteroid combination for moderate-to-severe allergic rhinitis in adults and children aged 12 and older. CF PharmTech said it was the first company in China to submit a generic clinical trial application for this product.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260308:nNDL9yY3wg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192634517","title":"CF PHARMTECH (02652) Included in Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=1192634517","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192634517?lang=en_us&edition=fundamental","pubTime":"2026-03-08 18:44","pubTimestamp":1772966656,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that its H shares have been officially included in the list of securities eligible for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs. This...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","VXUS","BK4585","BK4588","VT","BK1191","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164337640","title":"CF PHARMTECH (02652) Included in Shanghai-HK and Shenzhen-HK Stock Connect","url":"https://stock-news.laohu8.com/highlight/detail?id=1164337640","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164337640?lang=en_us&edition=fundamental","pubTime":"2026-03-08 18:42","pubTimestamp":1772966562,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that its H shares have been officially included in the list of eligible securities under both the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":8,"totalSize":151,"code":"91000000","status":"200"}]}}